OR WAIT null SECS
Rita C. Peters is editorial director of BioPharm International, Pharmaceutical Technology, and Pharmaceutical Technology Europe.
Survey results and record attendance may show positive signs for established and emerging biopharma regions.
Using the annual CPhI Worldwide tradeshow as a benchmark, the bio/pharma industry appears to be healthy and growing. Organizers of the 2018 event, held Oct. 9–11 in Madrid, Spain, reported attendance has increased by 9000 attendees compared with the last CPhI event in Madrid in 2015. Nearly 44,500 participants from 164 countries visited the event, which included more than 2500 exhibits, conference sessions, and networking opportunities (1).
Opinions about industry prospects around the globe also were revealed. In an annual study released during the event (2), CPhI reported results of a survey of bio/pharma professionals that ranked India, the United States, and China as the top regions for predicted pharma market growth. The US ranked first of 10 countries evaluated for reputation, followed by Germany, Japan, the United Kingdom, and France. India was ranked sixth; China was ranked last.
CPhI also measured perceptions of the knowledge of bioprocessing professionals, innovation, and quality with the US ranking first, followed again by Germany, Japan, and the UK. In a measure of growth potential, Ireland-home to planned expansions of bioprocessing capacity-ranked third.
In addition to the industry data, innovative technologies and services that support bio/pharma development, manufacturing, and distribution were recognized at the 2018 CPhI Pharma Awards Gala, held on Oct. 9, 2018. The winners are as follows:
CPhI and BioPharm International are UBM plc, a part of Informa brands.
1. CPhI, “Global Pharma Set for Strong Year with Record 164 Countries and 44,500 Attendees at CPhI Worldwide,” Press Release, Oct. 22, 2018.
2. CPhI, “CPhI’s Pharma Industry Rankings: A Snapshot of Pharma’s Health,” CPhI Annual Industry Report, October 2018.
Vol. 31, No. 11
When referring to this article, please cite it as R. Peters, " Innovation and Industry Strength Recognized at CPhI," BioPharm International 31 (11) 2018.